KATHERINE FRAZZETTA: Open Payments
NPI 1619211265 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 13 payments from 8 companies in 2025. Trend: 2023 $1,014 · 2024 $1,318 · 2025 $312
Food & beverage: $312
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $86 |
| ABBVIE INC. | 2 | $53 |
| PFIZER INC. | 2 | $41 |
| UCB, Inc. | 2 | $38 |
| Amneal Pharmaceuticals LLC | 2 | $35 |
| MDD US Operations, LLC | 1 | $22 |
| Biogen, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
Products named: QULIPTA, General - Therapies, NURTEC ODT, WaveWriter Alpha Prime 16, CREXONT, Briviact, Gocovri, LEQEMBI.
Industry payments across FL — which companies pay providers there.
